Mersana Therapeutics Total Assets (Quarterly) Insights

Mersana Therapeutics Inc (MRSN)

3.46 +0.10 (+2.98%) USD | NASDAQ | May 03, 16:00

3.455 0.00 (0.00%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	226.06M
September 30, 2023	262.90M
June 30, 2023	311.00M
March 31, 2023	296.20M
December 31, 2022	334.34M
September 30, 2022	314.85M
June 30, 2022	252.35M
March 31, 2022	258.27M
December 31, 2021	206.11M
September 30, 2021	217.59M
June 30, 2021	253.68M
March 31, 2021	247.91M
December 31, 2020	273.40M
September 30, 2020	290.13M
June 30, 2020	310.52M

Date	Value
March 31, 2020	95.86M
December 31, 2019	107.54M
September 30, 2019	121.66M
June 30, 2019	139.38M
March 31, 2019	149.39M
December 31, 2018	78.50M
September 30, 2018	94.38M
June 30, 2018	106.91M
March 31, 2018	115.76M
December 31, 2017	130.72M
September 30, 2017	142.92M
June 30, 2017	85.22M
March 31, 2017	95.01M
December 31, 2016	105.09M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

95.86M

Minimum

Mar 2020

334.34M

Maximum

Dec 2022

237.88M

Average

253.68M

Median

Jun 2021

Total Assets (Quarterly) Benchmarks

Amicus Therapeutics Inc	777.88M
Geron Corp	482.07M
TG Therapeutics Inc	373.32M
Editas Medicine Inc	499.15M
G1 Therapeutics Inc	121.54M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	189.16M
Shareholders Equity (Quarterly)	36.90M
Debt to Equity Ratio	0.6837
Current Ratio	3.364
Net Debt Paydown Yield	-0.03%